Your browser doesn't support javascript.
loading
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
Townsend, Elizabeth C; Murakami, Mark A; Christodoulou, Alexandra; Christie, Amanda L; Köster, Johannes; DeSouza, Tiffany A; Morgan, Elizabeth A; Kallgren, Scott P; Liu, Huiyun; Wu, Shuo-Chieh; Plana, Olivia; Montero, Joan; Stevenson, Kristen E; Rao, Prakash; Vadhi, Raga; Andreeff, Michael; Armand, Philippe; Ballen, Karen K; Barzaghi-Rinaudo, Patrizia; Cahill, Sarah; Clark, Rachael A; Cooke, Vesselina G; Davids, Matthew S; DeAngelo, Daniel J; Dorfman, David M; Eaton, Hilary; Ebert, Benjamin L; Etchin, Julia; Firestone, Brant; Fisher, David C; Freedman, Arnold S; Galinsky, Ilene A; Gao, Hui; Garcia, Jacqueline S; Garnache-Ottou, Francine; Graubert, Timothy A; Gutierrez, Alejandro; Halilovic, Ensar; Harris, Marian H; Herbert, Zachary T; Horwitz, Steven M; Inghirami, Giorgio; Intlekofer, Andrew M; Ito, Moriko; Izraeli, Shai; Jacobsen, Eric D; Jacobson, Caron A; Jeay, Sébastien; Jeremias, Irmela; Kelliher, Michelle A.
Affiliation
  • Townsend EC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Murakami MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Christodoulou A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Christie AL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Köster J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • DeSouza TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Morgan EA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Kallgren SP; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.
  • Liu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Wu SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Plana O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Montero J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Stevenson KE; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Rao P; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Vadhi R; Center for Functional Cancer Epigenomics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Andreeff M; Leukemia Division, MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Ballen KK; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Barzaghi-Rinaudo P; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Cahill S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Clark RA; Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Cooke VG; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Eaton H; Office of Research and Technology Ventures, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Ebert BL; Department of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Etchin J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Firestone B; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Fisher DC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Freedman AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Galinsky IA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Gao H; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Garcia JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Garnache-Ottou F; EFS Bourgogne Franche Comté, INSERM UMR1098, 25020 Besançon, France.
  • Graubert TA; Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Gutierrez A; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02215, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Halilovic E; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Harris MH; Department of Pathology, Boston Children's Hospital, Boston, MA 02215, USA.
  • Herbert ZT; Molecular Biology Core Facility, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Horwitz SM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
  • Inghirami G; Department of Pathology, Weill Cornell Medical College, New York, NY 10065, USA.
  • Intlekofer AM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
  • Ito M; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Izraeli S; Functional Genomics and Leukemia Research, Sheba Medical Center, Tel Hashomer and Tel Aviv University, Ramat Gan, 52621, Israel.
  • Jacobsen ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, 450 Brookline Avenue, Dana 510B, MA 02215, USA.
  • Jeay S; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA; Novartis Institutes for Biomedical Research, 4056 Basel, Switzerland.
  • Jeremias I; Department of Gene Vectors, Helmholtz Zentrum München, German Research Center for Environmental Health, Marchioninistraße 25, 81377 Munich, Germany; Department of Pediatrics, Dr. von Hauner Children's Hospital, Ludwig Maximilians University, Lindwurmstraße 4, 80337 Munich, Germany.
  • Kelliher MA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Cancer Cell ; 29(4): 574-586, 2016 04 11.
Article in En | MEDLINE | ID: mdl-27070704
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Banks / Leukemia / Xenograft Model Antitumor Assays / Heterografts / Lymphoma Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Banks / Leukemia / Xenograft Model Antitumor Assays / Heterografts / Lymphoma Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2016 Document type: Article Affiliation country: United States Country of publication: United States